Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors

Published:2023-11-02 Issue:19 Volume:149 Page:17597-17605
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Sperling Gabriel,Shatila Malek,Varatharajalu Krishnavathan,Lu Yang,Altan Mehmet,Zhou Yan,Zhao Dan,De Toni Enrico N.,Török Helga-Paula,Schneider Bryan J.,Khan Anam,Thomas Anusha S.,Zhang Hao Chi,Shafi Mehnaz A.,Wang Yinghong

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05461-z.pdf

Reference29 articles.

1. Badgwell B, Feig BW, Ross MI et al (2007) Pneumoperitoneum in the cancer patient. Ann Surg Oncol 14:3141–3147. https://doi.org/10.1245/s10434-007-9510-9

2. Bhamidipati PK, Ghobadi A, Bauer S et al (2014) Conservative management of pneumatosis intestinalis after allogeneic hematopoietic SCT. Bone Marrow Transplant 49:1436–1438. https://doi.org/10.1038/bmt.2014.148

3. Buchbinder EI, Desai A (2016) CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol 39:98–106. https://doi.org/10.1097/COC.0000000000000239

4. Chaudhry NS, Bi WL, Gupta S et al (2019) Pneumatosis intestinalis after molecular-targeted therapy. World Neurosurg 125:312–315. https://doi.org/10.1016/j.wneu.2019.01.225

5. Ellis BW (1980) Symptomatic treatment of primary pneumatosis coli with metronidazole. Br Med J 280:763–764. https://doi.org/10.1136/bmj.280.6216.763-a

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the research landscape of drug resistance and therapeutic approaches in head and neck cancer: a bibliometric analysis from 2000 to 2023;Frontiers in Pharmacology;2024-04-05

2. Pneumatosis Intestinalis, Pneumoperitoneum, Pneumoretroperitoneum, Pneumomediastinum, and Pneumobilia After Pembrolizumab Therapy: A Case Report;Cureus;2024-03-11